Impaired antibody response in an AIDS patient compromised the accuracy of the test. The OraQuick Advance Rapid HIV-1 Antibody Test has transformed HIV testing from a cumbersome process to a rapid ...
MedMira receives Health Canada approval for its Multiplo(R) Rapid (TP/HIV) Test for Syphilis and HIV
The Multiplo® TP/HIV rapid test allows healthcare professional to accurately detect both HIV-1/2 and syphilis antibodieswith one sample using a simple finger prick that delivers results immediately.
The performance characteristics of a sequential rapid HIV-testing algorithm were poorer than anticipated in a Ugandan study, perhaps due to false-positive results from tests with "faint bands." Rapid ...
I had HIV exposure with someone who is confirmed as HIV positive (he admitted it when I confronted him). For a different reason, I was administered a three-day dexamethasone injection of high dosages.
The INSTI® HIV Self Test delivers highly accurate results in 60 seconds or less, the fastest home-use HIV rapid test available. FDA-approved and ready for U.S. consumers, providing a private and ...
One in every 50 people screened for a suspected sexually transmitted infection (STI) in the Emergency Department at Henry Ford Hospital was found to be infected with HIV using a rapid blood sample ...
HALIFAX, NS / ACCESSWIRE / January 14, 2025 / MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has received today the approval from Health Canada for its Reveal®Rapid G4 HIV-1/2 Test (Reveal® ...
The thought of robots taking over our jobs—and doing them better than we ever could—isn’t always a particularly welcoming thought. One major exception is when artificial intelligence software can ...
A new high-tech rapid HIV and Aids test kit and point of care cluster of differentiation (CD4) has been unveiled in the country making early diagnosis of the virus possible. Called Alere Determine ...
MedMira receives Health Canada approval for its Multiplo(R) Rapid (TP/HIV) Test for Syphilis and HIV
HALIFAX, NS / ACCESSWIRE / December 24, 2024 / MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has received today, on December 24, 2024, the approval from Health Canada for its Multiplo ® ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results